Rare diseases
Investigational molecules
Locations
378 conditions with trials, the busiest first
838 trials across Europe, recruiting first
Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine
CzechiaStudy on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
BelgiumStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
BelgiumStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
AustriaStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
AustriaStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
AustriaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
BulgariaStudy on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults
CzechiaStudy on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults
CzechiaStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
BulgariaThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
